about
Integrated Models of Care for People Living with Hepatitis C Virus and a Substance Use Disorder: Protocol for a Systematic Review.Trajectories of retention in opioid agonist therapy in a Canadian settingThe tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisisHigh-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysisSuccessful treatment with slow-release oral morphine following afentanyl-related overdose: A case reportThe cascade of care for opioid use disorder: a retrospective study in British Columbia, CanadaIntegrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review
P50
Q54216905-16C6E06C-FD82-4EEE-B888-6A1BCF768A5CQ89680628-FAC9A6B8-8DC3-4565-8486-0C411275020EQ91456225-3EBDD2CF-4241-4709-A58D-F34A3B6CAF01Q91608116-CBB1204F-73D6-4F17-9809-C0481BAEBD85Q92094527-B3FCFF1F-ED14-4543-AD89-B7D1B2654FCCQ92400236-FF3EF4FE-2AEB-419B-A17D-029E6626F972Q92416380-8E303FE1-BB35-4314-858B-D6B977773FCD
P50
description
researcher
@en
wetenschapper
@nl
name
María Eugenia Socías
@en
María Eugenia Socías
@nl
type
label
María Eugenia Socías
@en
María Eugenia Socías
@nl
prefLabel
María Eugenia Socías
@en
María Eugenia Socías
@nl
P31
P496
0000-0003-2556-7049